Loading…
A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome
Hyperparathyroidism–jaw tumour syndrome (HPT-JT) is a rare variant of familial hyperparathyroidism, characterized by primary hyperparathyroidism (PHPT) due to one or multiple parathyroid adenomas, and benign tumours of the mandible and maxilla. It has an autosomal dominant pattern of inheritance, an...
Saved in:
Published in: | Endocrine pathology 2016-06, Vol.27 (2), p.142-146 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83 |
---|---|
cites | cdi_FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83 |
container_end_page | 146 |
container_issue | 2 |
container_start_page | 142 |
container_title | Endocrine pathology |
container_volume | 27 |
creator | Bellido, Virginia Larrañaga, Ihintza Guimón, Maite Martinez-Conde, Rafael Eguia, Asier Perez de Nanclares, Gustavo Castaño, Luis Gaztambide, Sonia |
description | Hyperparathyroidism–jaw tumour syndrome (HPT-JT) is a rare variant of familial hyperparathyroidism, characterized by primary hyperparathyroidism (PHPT) due to one or multiple parathyroid adenomas, and benign tumours of the mandible and maxilla. It has an autosomal dominant pattern of inheritance, and is associated with mutations that deactivate the cell division cycle protein 73 homolog (
CDC73
) gene, also known as hyperparathyroidism 2 (
HRPT2
), located on the long arm of chromosome 1, that encodes for the tumour suppressor protein parafibromin. In the majority of cases, PHPT is the presenting symptom, but up to 30 % of HPT-JT cases initially present with an ossifying fibroma of the maxillofacial bones. HPT-JT may result in severe hypercalcemia-related complications and an elevated risk of parathyroid carcinoma. For this reason, early identification of the disease is important. We present the case of a 23-year-old woman who was found to have jaw tumours and was later diagnosed with PHPT. Genetic analysis revealed a novel mutation in exon 1 of
CDC73
. This report contributes to the understanding of the genetics of this rare syndrome. It also highlights the fact that HPT-JT should be considered and
CDC73
mutation analysis should be performed in cases of early-onset PHPT associated with ossifying fibromas of the jaw. |
doi_str_mv | 10.1007/s12022-016-9427-6 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1785214024</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4035724341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83</originalsourceid><addsrcrecordid>eNp1kEtOwzAQhi0EoqVwADbIEhs2gbFjO_GyqoCCykOirC0ncWiqPIqdUHXHHbghJ8FVC0JIrDySv_ln5kPomMA5AYguHKFAaQBEBJLRKBA7qE84lwGAjHZ9DUwEoYxEDx04NwcgIQDdRz0qpOQe6qPJEN83b6bEd12r26KpcVFjjR99beoWL4t2hserhbELbXU7W9mmyApXfb5_3OolnnZV01n8tKoz21TmEO3lunTmaPsO0PPV5XQ0DiYP1zej4SRIw4i2QRJxLrgWiTESwpBwwYy_h1BGE5nmmog0jTkwyI3kIZgsSRItSa61yECmcThAZ5vchW1eO-NaVRUuNWWpa9N0TpEo5pQwoMyjp3_Qud-49tutKcZIHPHQU2RDpbZxzppcLWxRabtSBNRatdqoVl61WqtWwvecbJO7pDLZT8e3Ww_QDeD8V_1i7K_R_6Z-ASTmiRk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1784418753</pqid></control><display><type>article</type><title>A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome</title><source>Springer Link</source><creator>Bellido, Virginia ; Larrañaga, Ihintza ; Guimón, Maite ; Martinez-Conde, Rafael ; Eguia, Asier ; Perez de Nanclares, Gustavo ; Castaño, Luis ; Gaztambide, Sonia</creator><creatorcontrib>Bellido, Virginia ; Larrañaga, Ihintza ; Guimón, Maite ; Martinez-Conde, Rafael ; Eguia, Asier ; Perez de Nanclares, Gustavo ; Castaño, Luis ; Gaztambide, Sonia</creatorcontrib><description>Hyperparathyroidism–jaw tumour syndrome (HPT-JT) is a rare variant of familial hyperparathyroidism, characterized by primary hyperparathyroidism (PHPT) due to one or multiple parathyroid adenomas, and benign tumours of the mandible and maxilla. It has an autosomal dominant pattern of inheritance, and is associated with mutations that deactivate the cell division cycle protein 73 homolog (
CDC73
) gene, also known as hyperparathyroidism 2 (
HRPT2
), located on the long arm of chromosome 1, that encodes for the tumour suppressor protein parafibromin. In the majority of cases, PHPT is the presenting symptom, but up to 30 % of HPT-JT cases initially present with an ossifying fibroma of the maxillofacial bones. HPT-JT may result in severe hypercalcemia-related complications and an elevated risk of parathyroid carcinoma. For this reason, early identification of the disease is important. We present the case of a 23-year-old woman who was found to have jaw tumours and was later diagnosed with PHPT. Genetic analysis revealed a novel mutation in exon 1 of
CDC73
. This report contributes to the understanding of the genetics of this rare syndrome. It also highlights the fact that HPT-JT should be considered and
CDC73
mutation analysis should be performed in cases of early-onset PHPT associated with ossifying fibromas of the jaw.</description><identifier>ISSN: 1046-3976</identifier><identifier>EISSN: 1559-0097</identifier><identifier>DOI: 10.1007/s12022-016-9427-6</identifier><identifier>PMID: 26995009</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adenoma - genetics ; DNA Mutational Analysis ; Endocrinology ; Female ; Fibroma - genetics ; Humans ; Hyperparathyroidism - genetics ; Jaw Neoplasms - genetics ; Medicine ; Medicine & Public Health ; Mutation ; Oncology ; Pathology ; Polymerase Chain Reaction ; Tumor Suppressor Proteins - genetics ; Young Adult</subject><ispartof>Endocrine pathology, 2016-06, Vol.27 (2), p.142-146</ispartof><rights>Springer Science+Business Media New York 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83</citedby><cites>FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26995009$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bellido, Virginia</creatorcontrib><creatorcontrib>Larrañaga, Ihintza</creatorcontrib><creatorcontrib>Guimón, Maite</creatorcontrib><creatorcontrib>Martinez-Conde, Rafael</creatorcontrib><creatorcontrib>Eguia, Asier</creatorcontrib><creatorcontrib>Perez de Nanclares, Gustavo</creatorcontrib><creatorcontrib>Castaño, Luis</creatorcontrib><creatorcontrib>Gaztambide, Sonia</creatorcontrib><title>A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome</title><title>Endocrine pathology</title><addtitle>Endocr Pathol</addtitle><addtitle>Endocr Pathol</addtitle><description>Hyperparathyroidism–jaw tumour syndrome (HPT-JT) is a rare variant of familial hyperparathyroidism, characterized by primary hyperparathyroidism (PHPT) due to one or multiple parathyroid adenomas, and benign tumours of the mandible and maxilla. It has an autosomal dominant pattern of inheritance, and is associated with mutations that deactivate the cell division cycle protein 73 homolog (
CDC73
) gene, also known as hyperparathyroidism 2 (
HRPT2
), located on the long arm of chromosome 1, that encodes for the tumour suppressor protein parafibromin. In the majority of cases, PHPT is the presenting symptom, but up to 30 % of HPT-JT cases initially present with an ossifying fibroma of the maxillofacial bones. HPT-JT may result in severe hypercalcemia-related complications and an elevated risk of parathyroid carcinoma. For this reason, early identification of the disease is important. We present the case of a 23-year-old woman who was found to have jaw tumours and was later diagnosed with PHPT. Genetic analysis revealed a novel mutation in exon 1 of
CDC73
. This report contributes to the understanding of the genetics of this rare syndrome. It also highlights the fact that HPT-JT should be considered and
CDC73
mutation analysis should be performed in cases of early-onset PHPT associated with ossifying fibromas of the jaw.</description><subject>Adenoma - genetics</subject><subject>DNA Mutational Analysis</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Fibroma - genetics</subject><subject>Humans</subject><subject>Hyperparathyroidism - genetics</subject><subject>Jaw Neoplasms - genetics</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mutation</subject><subject>Oncology</subject><subject>Pathology</subject><subject>Polymerase Chain Reaction</subject><subject>Tumor Suppressor Proteins - genetics</subject><subject>Young Adult</subject><issn>1046-3976</issn><issn>1559-0097</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kEtOwzAQhi0EoqVwADbIEhs2gbFjO_GyqoCCykOirC0ncWiqPIqdUHXHHbghJ8FVC0JIrDySv_ln5kPomMA5AYguHKFAaQBEBJLRKBA7qE84lwGAjHZ9DUwEoYxEDx04NwcgIQDdRz0qpOQe6qPJEN83b6bEd12r26KpcVFjjR99beoWL4t2hserhbELbXU7W9mmyApXfb5_3OolnnZV01n8tKoz21TmEO3lunTmaPsO0PPV5XQ0DiYP1zej4SRIw4i2QRJxLrgWiTESwpBwwYy_h1BGE5nmmog0jTkwyI3kIZgsSRItSa61yECmcThAZ5vchW1eO-NaVRUuNWWpa9N0TpEo5pQwoMyjp3_Qud-49tutKcZIHPHQU2RDpbZxzppcLWxRabtSBNRatdqoVl61WqtWwvecbJO7pDLZT8e3Ww_QDeD8V_1i7K_R_6Z-ASTmiRk</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Bellido, Virginia</creator><creator>Larrañaga, Ihintza</creator><creator>Guimón, Maite</creator><creator>Martinez-Conde, Rafael</creator><creator>Eguia, Asier</creator><creator>Perez de Nanclares, Gustavo</creator><creator>Castaño, Luis</creator><creator>Gaztambide, Sonia</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20160601</creationdate><title>A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome</title><author>Bellido, Virginia ; Larrañaga, Ihintza ; Guimón, Maite ; Martinez-Conde, Rafael ; Eguia, Asier ; Perez de Nanclares, Gustavo ; Castaño, Luis ; Gaztambide, Sonia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenoma - genetics</topic><topic>DNA Mutational Analysis</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Fibroma - genetics</topic><topic>Humans</topic><topic>Hyperparathyroidism - genetics</topic><topic>Jaw Neoplasms - genetics</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mutation</topic><topic>Oncology</topic><topic>Pathology</topic><topic>Polymerase Chain Reaction</topic><topic>Tumor Suppressor Proteins - genetics</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bellido, Virginia</creatorcontrib><creatorcontrib>Larrañaga, Ihintza</creatorcontrib><creatorcontrib>Guimón, Maite</creatorcontrib><creatorcontrib>Martinez-Conde, Rafael</creatorcontrib><creatorcontrib>Eguia, Asier</creatorcontrib><creatorcontrib>Perez de Nanclares, Gustavo</creatorcontrib><creatorcontrib>Castaño, Luis</creatorcontrib><creatorcontrib>Gaztambide, Sonia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bellido, Virginia</au><au>Larrañaga, Ihintza</au><au>Guimón, Maite</au><au>Martinez-Conde, Rafael</au><au>Eguia, Asier</au><au>Perez de Nanclares, Gustavo</au><au>Castaño, Luis</au><au>Gaztambide, Sonia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome</atitle><jtitle>Endocrine pathology</jtitle><stitle>Endocr Pathol</stitle><addtitle>Endocr Pathol</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>27</volume><issue>2</issue><spage>142</spage><epage>146</epage><pages>142-146</pages><issn>1046-3976</issn><eissn>1559-0097</eissn><abstract>Hyperparathyroidism–jaw tumour syndrome (HPT-JT) is a rare variant of familial hyperparathyroidism, characterized by primary hyperparathyroidism (PHPT) due to one or multiple parathyroid adenomas, and benign tumours of the mandible and maxilla. It has an autosomal dominant pattern of inheritance, and is associated with mutations that deactivate the cell division cycle protein 73 homolog (
CDC73
) gene, also known as hyperparathyroidism 2 (
HRPT2
), located on the long arm of chromosome 1, that encodes for the tumour suppressor protein parafibromin. In the majority of cases, PHPT is the presenting symptom, but up to 30 % of HPT-JT cases initially present with an ossifying fibroma of the maxillofacial bones. HPT-JT may result in severe hypercalcemia-related complications and an elevated risk of parathyroid carcinoma. For this reason, early identification of the disease is important. We present the case of a 23-year-old woman who was found to have jaw tumours and was later diagnosed with PHPT. Genetic analysis revealed a novel mutation in exon 1 of
CDC73
. This report contributes to the understanding of the genetics of this rare syndrome. It also highlights the fact that HPT-JT should be considered and
CDC73
mutation analysis should be performed in cases of early-onset PHPT associated with ossifying fibromas of the jaw.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>26995009</pmid><doi>10.1007/s12022-016-9427-6</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1046-3976 |
ispartof | Endocrine pathology, 2016-06, Vol.27 (2), p.142-146 |
issn | 1046-3976 1559-0097 |
language | eng |
recordid | cdi_proquest_miscellaneous_1785214024 |
source | Springer Link |
subjects | Adenoma - genetics DNA Mutational Analysis Endocrinology Female Fibroma - genetics Humans Hyperparathyroidism - genetics Jaw Neoplasms - genetics Medicine Medicine & Public Health Mutation Oncology Pathology Polymerase Chain Reaction Tumor Suppressor Proteins - genetics Young Adult |
title | A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T08%3A49%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Novel%20Mutation%20in%20a%20Patient%20with%20Hyperparathyroidism%E2%80%93Jaw%20Tumour%20Syndrome&rft.jtitle=Endocrine%20pathology&rft.au=Bellido,%20Virginia&rft.date=2016-06-01&rft.volume=27&rft.issue=2&rft.spage=142&rft.epage=146&rft.pages=142-146&rft.issn=1046-3976&rft.eissn=1559-0097&rft_id=info:doi/10.1007/s12022-016-9427-6&rft_dat=%3Cproquest_cross%3E4035724341%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-b75565a6bee90331564e1001242b9cfa16cc85040fe9530edbbba91faa6d09c83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1784418753&rft_id=info:pmid/26995009&rfr_iscdi=true |